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Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are permeable to Na ϩ /K ϩ and underlie the inwardly rectifying current termed I h , I(f), or I q (Santoro and Tibbs, 1999) . Regulated by voltage and the binding of ligands, there are four HCN isoforms that vary in their activation kinetics. These currents contribute to the control of excitability, plasticity, and rhythmicity in cardiac cells and neurons throughout the CNS. In hippocampal pyramidal neurons, cAMPinsensitive I h currents affect input resistance (IR) and temporal summation (TS) of EPSPs, thereby influencing dendritic synaptic integration. The kinetics and distribution of I h are the principal factors influencing temporal summation and subsequent synchronization of CA1 hippocampal neurons (Magee, 1999) . Recent studies have implicated these channels in learning and memory (Nolan et al., 2003) and the pathophysiology of diseases involving neuronal excitability such as epilepsy (Ludwig et al., 2003) . Based on data from excised patches of exogenously expressed HCN1 or HCN2 channels, which display a hyperpolarized shift in voltage-dependent activation independent of cAMP activity, Poolos et al. (2006) hypothesized that alternative proteins associated with the membrane patch contribute to the regulation of I h activity. To determine modulators of HCN activity, in their recent paper in The Journal of Neuroscience, Poolos et al. (2006) identify p38 mitogen-activated protein kinase (MAPK) through computational analysis and examined its effects on I h .
The authors initially screened and identified 12 potential kinase modulators of HCN1 and HCN2 using the Scansite software tool [Poolos et al. (2006) , their Table 1 (http://www.jneurosci.org/cgi/ content/full/26/30/7995/T1)]. Based on the highest level of stringency and likelihood of interaction with HCN1 and HCN2, the authors chose to examine the modulatory effect of p38 MAPK. Using adult rat hippocampal slices, the authors examined I h in CA1 pyramidal dendrites and pyramidal-like principal (PLP) neurons. Although biocytin fills of these neurons showed a similar apical dendritic morphology [Poolos et al. (2006) , their Fig. 1 A, B (http://www.jneurosci.org/cgi/ content/full/26/30/7995/F1)], these two cell types had opposite somatodendritic I h distributions. CA1 neurons had a high dendritic and low somatic I h density, whereas PLP neurons had a high somatic I h density, allowing the authors to examine I h in somatic recordings. In both cell types, macroscopic I h currents were recorded in cell-attached patch-clamp mode at various hyperpolarizing potentials, and the activation kinetics were fitted with a double exponential. The biophysical properties of I h currents were similar in maximal density, voltagedependent activation [Poolos et al. (2006) . The authors argue that, because JNK inhibition did not modulate I h activation, anisomycin must act to upregulate I h via activation of p38 MAPK. These experiments show that resting levels of activated MAPK dynamically modulate I h activation. It would be interesting to see whether the effects of the antiepileptic drug lamotrigine, which the authors mention shifts I h activation in a depolarized direction, can be abolished by coapplication with SB203580.
Next, the authors assessed whether IR and TS would be altered by modulating p38 MAPK levels. The MAPK inhibitor SB203580 caused ϳ72 and ϳ85% increase in IR in CA1 dendrites and PLP neurons, consistent with a decrease in active I h [Poolos et al. (2006) Poolos et al. (2006) provide the first evidence that p38 MAPK robustly regulates I h activity, shifting the number of channels active at the resting membrane potential and thus profoundly affecting hippocampal neuronal excitability (illustrated in Fig. 1 ). Although it is unknown whether p38 MAPK directly phosphorylates HCN channels, Poolos et al. (2006) pave the way for such studies. Furthermore, these results identify p38 MAPK as a potential therapeutic target for diseases such as epilepsy and cardiac arrhythmia in which HCN channels have been implicated. 
